Skip to main content


Testosterone Replacement Therapy Lawyer

Have you taken testosterone replacement therapies AndroGel, Axiron, Testim or AndroDerm and suffered a heart attack, stroke or pulmonary embolism? If you have, you may have a claim that your cardiovascular event was the result of this testosterone therapy. Our testosterone replacement therapy attorneys are well-equipped to answer your questions and provide the legal guidance you need.

Two new studies show a link between testosterone replacement therapies and heart attack and/or stroke. In November 2013, a study published in the Journal of the American Medical Association showed that testosterone replacement therapies are linked to an increased risk of heart attack, stroke or death in older men with pre-existing heart conditions. In January 2013, another study published in PLOSOne, another medical journal, found that low testosterone treatments may double the risk of heart attack in younger men with pre-existing heart conditions and in older men with no pre-existing heart conditions.

With an office in Williamsport, our lawyers are prepared to represent clients throughout Pennsylvania.

On January 31, 2014, the FDA announced it is investigating the safety of testosterone therapies in response to these new studies, including the potential for heart attack, stroke or even death.
In recent years, testosterone therapies including AndroGel have increased sales by more than a factor of five, generating more than $1.9 billion in sales in 2012.

If you or someone you loved took Androgel, Axiron, AndroDerm or Testim and suffered a heart attack, stroke, or pulmonary embolism, contact our atorneys at Rieders, Travis, Dohrmann, Mowrey, Humphrey & Waters to determine if you have a claim. Lawsuits are presently being filed in federal U.S. District Court for the Northern District of Illinois and other federal courts.

Attorney Cliff Rieders

Attorney Cliff RiedersCliff Rieders is a Nationally Board Certified Trial Lawyer practicing personal injury law. A large part of his practice involves multi-district litigation, including cases related to pharmaceuticals, vitamin supplements and medical devices. He is admitted in several state and federal courts, as well as the Supreme Court of the United States. Rieders is the past regional president of the Federal Bar Association and is a life member of the distinguished American Law Institute, which promulgates proposed rules adopted by many state courts. He is a past president of the Pennsylvania Association for Justice, formerly Pennsylvania Trial Lawyers Association. As a founder of the Pennsylvania Patient Safety Authority, he served on the Board for 15 years.

Not only has Rieders held many highly esteemed, leadership positions, he authored legislation related to the Patient Safety Authority and the Mcare Act, which governs medical and hospital liability actions in Pennsylvania. He authored texts upon which both practitioners and judges rely, including Pennsylvania Malpractice Laws and Forms, and Financial Responsibility Law Issues in Pennsylvania, the latter governing auto and truck collisions in Pennsylvania. In addition, he wrote several books on the practice of law in Pennsylvania regarding wrongful death and survivor actions, insurance bad faith, legal malpractice claims and worker rights, among others. Rieders also serves as a resource to practitioners as a regular speaker for Celesq, an arm of the world’s largest legal publisher, Thomson Reuters West Publishing.

As recognition of his wide range of contribution to his profession and of his dedication to protecting the rights of his clients, he received numerous awards, among them the George F. Douglas Amicus Curiae Award, the Milton D. Rosenberg Award, the B’nai B’rith Justice Award, and awards of recognition from the Pennsylvania Trial Lawyers. [ Attorney Bio ]